[{"id":"59cd4907-7414-4a7a-8621-ea3eec8b43bb","acronym":"","url":"https://clinicaltrials.gov/study/NCT00736645","created_at":"2023-10-02T22:10:46.115Z","updated_at":"2024-07-02T16:35:35.090Z","phase":"Phase 2","brief_title":"Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer","source_id_and_acronym":"NCT00736645","lead_sponsor":"Roswell Park Cancer Institute","biomarkers":" CASP3","pipe":"","alterations":" ","tags":["CASP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e finasteride • selenomethionine (SLM)"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 08/01/2008","start_date":" 08/01/2008","primary_txt":" Primary completion: 12/01/2012","primary_completion_date":" 12/01/2012","study_txt":" Completion: 12/01/2012","study_completion_date":" 12/01/2012","last_update_posted":"2023-10-02"}]